Return on Assets (ROA): 7.29%
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 7.29% is 69% above its 5-year average of 4.33%, near the high end of its 5-year range (0.99%–7.31%).
As of Friday, June 26, 2026. 9.05% above its 12-month average of 6.68%.
STE Return on Assets (ROA) Chart
Annual fiscal-year return on assets; no daily interpolation.
STE Average Return on Assets (ROA) Chart
STE Current vs Average Return on Assets (ROA) Chart
STE Return on Assets (ROA) Metrics
RETURN ON ASSETS (ROA)
7.29%
RETURN ON ASSETS (ROA) AVG TTM
6.68%
RETURN ON ASSETS (ROA) AVG 3Y
4.44%
RETURN ON ASSETS (ROA) AVG 5Y
4.33%
RETURN ON ASSETS (ROA) AVG 10Y
4.48%
RETURN ON ASSETS (ROA) AVG 15Y
5.31%
RETURN ON ASSETS (ROA) AVG 20Y
5.87%
CURRENT VS TTM AVG
+9.05%
CURRENT VS 3Y AVG
+64.00%
CURRENT VS 5Y AVG
+68.55%
CURRENT VS 10Y AVG
+62.59%
CURRENT VS 15Y AVG
+37.27%
CURRENT VS 20Y AVG
+24.10%
STE Competitors' Return on Assets (ROA)
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| STERIS plc (STE) | $20.52B | 7.29% | 6.68% | 4.44% | 4.33% |
| Incyte Corporation (INCY)vs › | $21.48B | 19.51% | 9.54% | 8.43% | 7.44% |
| Labcorp Holdings Inc. (LH)vs › | $21.83B | 4.93% | 4.41% | 4.42% | 6.18% |
| Viatris Inc. (VTRS)vs › | $18.71B | -0.80% | -5.49% | -1.68% | -1.68% |
| BioNTech SE (BNTX)vs › | $22.76B | -6.03% | -3.96% | 9.16% | 17.06% |
| Quest Diagnostics Incorporated (DGX)vs › | $22.83B | 6.14% | 5.75% | 6.24% | 8.30% |
| United Therapeutics Corporation (UTHR)vs › | $23.07B | 19.17% | 16.59% | 14.73% | 13.22% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $17.60B | 3.35% | 3.64% | 3.29% | 2.38% |
| Moderna, Inc. (MRNA)vs › | $23.71B | -27.80% | -24.02% | -10.32% | -0.33% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 5.92% | 7.45% | 8.56% | 11.79% |
Asset Efficiency
ROA
7.3%
ROE
10.9%
Return on Assets (ROA) Formula & Definition
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Return on Assets (ROA) FAQ
- What is the return on assets (ROA) for STERIS plc (STE)?
- The return on assets (ROA) for STE stock is 7.29%.
- Is STERIS plc's return on assets (ROA) high or low?
- The return on assets (ROA) of 7.29% is 69% above its 5-year average of 4.33%, near the high end of its 5-year range (0.99%–7.31%).
- What is the TTM average return on assets (ROA) for STERIS plc (STE)?
- The TTM average return on assets (ROA) for STE stock is 6.68%.
- What is the 3Y average return on assets (ROA) for STERIS plc (STE)?
- The 3Y average return on assets (ROA) for STE stock is 4.44%.
- What is the 5Y average return on assets (ROA) for STERIS plc (STE)?
- The 5Y average return on assets (ROA) for STE stock is 4.33%.
- What is the 10Y average return on assets (ROA) for STERIS plc (STE)?
- The 10Y average return on assets (ROA) for STE stock is 4.48%.
- What is the 15Y average return on assets (ROA) for STERIS plc (STE)?
- The 15Y average return on assets (ROA) for STE stock is 5.31%.
- What is the 20Y average return on assets (ROA) for STERIS plc (STE)?
- The 20Y average return on assets (ROA) for STE stock is 5.87%.
STE Return on Assets (ROA) History
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-03-31 | 7.31% |
| 2025-03-31 | 6.06% |
| 2024-03-31 | 3.42% |
| 2023-03-31 | 0.99% |
| 2022-03-31 | 2.13% |
| 2021-03-31 | 6.04% |
| 2020-03-31 | 7.49% |
| 2019-03-31 | 5.99% |
| 2018-03-31 | 5.59% |
| 2017-03-31 | 2.23% |
| 2016-03-31 | 2.07% |
| 2015-03-31 | 6.44% |
| 2014-03-31 | 6.86% |
| 2013-03-31 | 9.08% |
| 2012-03-31 | 9.68% |
| 2011-03-31 | 3.59% |
| 2010-03-31 | 10.37% |
| 2009-03-31 | 9.10% |
| 2008-03-31 | 6.22% |
| 2007-03-31 | 6.79% |
| 2006-03-31 | 5.91% |
| 2005-03-31 | 7.25% |
| 2004-03-31 | 8.82% |
| 2003-03-31 | 8.88% |
| 2002-03-31 | 5.49% |
| 2001-03-31 | 0.16% |
| 2000-03-31 | 1.16% |
| 1999-03-31 | 9.80% |
| 1998-03-31 | 8.94% |
| 1997-03-31 | -5.67% |
Related Metrics
About STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Daniel A. Carestio